Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-24 @ 11:42 PM
NCT ID: NCT06860451
Eligibility Criteria: Inclusion Criteria: * Onset of stroke \<6 months ago, or \>6 months since the last stroke event; * Age \>=18 years and \<85 years (as the probability of Vascular Cognitive Impairment increases above 85); * Patients with damage in the middle cerebral artery territory; * NIHSS \>4 and \<26; * mRS score \>=2; * Completion of CT or MRI; * No neurological or psychiatric disorders; no impairment of consciousness; able to comply with relevant treatments; no severe cognitive dysfunction (MMSE \>=15); * All participants are right-handed; Sign the informed consent form. Exclusion Criteria: * History of epilepsy or psychiatric disorders (including depression, anxiety, or schizophrenia); * Severe comorbidities; * History of medication use: benzodiazepines, baclofen, antidepressants; * Non-compliance with the treatment plan; * Acute-phase cerebral hemorrhage, acute infectious diseases; * Severe suicidal tendencies in individuals with depression; * Individuals suffering from severe headaches, high blood pressure, malignant tumors, open wounds, vascular embolism, leukopenia, etc.; * Severe alcohol abuse; * History of cranial surgery, individuals with metal implants in the brain; * Individuals with an implanted cardiac pacemaker; * NIHSS \>26, MMSE \<15; * Any disease likely to prevent the patient from surviving more than one month; * Pregnant individuals.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT06860451
Study Brief:
Protocol Section: NCT06860451